 |
市场调查报告书
商品编码
1290602
皮下给药市场：按可用性、按适应症（、按输送系统、按地区-规模、份额、展望、机会分析，2023-2030Subcutaneous Drug Delivery Market, By Usability, Disease Indication(Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, & Others), Delivery System, & Region-Size, Share, Outlook, & Opportunity Analysis, 2023-2030 |
||||||
价格
简介目录
预充式註射器和自动注射器的技术创新和开发正在促进市场的增长。 例如，德国初级包装製造商Gerresheimer于2020年6月宣布推出适用于生物技术生产的活性成分的完美初级包装，该包装不含钨，完美地消除了金属污染的可能性，并推出了Lure Lock Gx RTF注射器。
此外，2022 年 3 月，医疗设备製造商 YpsoMed 开发了 YpsoMate SmartPilot，这是其专有 YpsoMate 笔的可重复使用附件，可简化两步注射过程。 该设备配备了传感器和内存，通过将其连接到应用程序，可以显示注射时间和剂量。 该笔向用户提供音频和视觉反馈。 该应用程序还可以提醒用户何时注射胰岛素。
市场动态
监管机构的产品批准预计将在预测期内推动市场增长。 例如，2023 年 3 月 6 日，其全球生物仿製药公司 Coherus BioSciences, Inc. 宣布美国食品和药物管理局 (FDA) 批准推出 UDENYCA (pegfilgrastim-cbqv) 单剂量预充式自动注射器。它做了。 UDENYCA 自动注射器采用流线型且用户友好的设计，适合办公室和家庭护理使用。
本研究的主要特点
- 本报告对全球皮下给药市场进行了深入分析，提供了以 2022 年为基准年的预测期（2023-2030 年）的市场规模和復合年增长率。
- 它还阐明了各个细分市场的潜在收入机会，并概述了该市场有吸引力的投资主张矩阵。
- 它还提供了有关市场驱动因素、限制因素、机遇、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
- 根据公司概况、业绩、产品组合、市场占有率、分销策略、主要发展、战略和未来计划等参数，介绍全球皮下给药市场的主要参与者。
- 本研究涵盖的主要公司包括 Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG 和其他知名关键参与者。
- 从本报告中获得的见解将使企业营销人员和管理层能够就未来的产品发布、技术升级、市场扩张和营销策略做出明智的决策。
- 《全球皮下给药市场报告》面向该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
- 利益相关者可以通过用于分析全球皮下给药市场的各种策略矩阵来促进决策。
内容
第 1 章目的和先决条件
- 调查目的
- 先决条件
- 缩写
第 2 章市场展望
- 报告摘要
- 市场定义和范围
- 执行摘要
- 市场概况：按可用性分类
- 市场概况：按迹象分类
- 市场概况：按交付系统分类
- 市场概况：按分销渠道划分
- 市场概况：按地区
- 连贯的机会地图 (COM)
第 3 章市场动态、监管与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 市场机会
- 影响分析
- 最近的产品公告
- 合併、收购、联合研究
- 产品发布
- 监管场景
- PEST分析
第 4 章全球皮下给药市场 - 冠状病毒 (COVID-19) 大流行的影响
- 经济影响
- COVID-19 的流行病学
- 对供需的影响
第 5 章全球皮下给药市场：按可用性划分，2017-2030
- 一次性
- 可重复使用
第 6 章全球皮下给药市场：按适应症分类，2017-2030
- 自身免疫性疾病
- 神经系统疾病
- 肿瘤疾病
- 荷尔蒙失调
- 过敏和传染病
- 眼科疾病
- 其他
第 7 章全球皮下给药市场：按给药系统划分，2017-2030 年
- 预灌封注射器
- 自动注射器
- 笔式注射器
- 一次性
- 其他（泵等）
第 8 章全球皮下给药市场：按分销渠道划分，2017-2030 年
- 医院药房
- 零售药店
- 网上药店
第 9 章2017-2030年按地区划分的全球皮下给药市场
- 北美
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地区
- 欧洲
- 英国
- 德国
- 意大利
- 法国
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 东盟
- 澳大利亚
- 韩国
- 亚太地区其他地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中非
- 南非
第 10 章竞争格局
- 公司简介
- Becton Dickinson and Company
- Novo Nordisk A/S
- Johnson & Johnson.
- Novartis International AG
- Amgen, Inc
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.
- Consort Medical plc.
- LaVision Biotec GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation
- West Pharmaceutical Services, Inc.
- Gerresheimer AG.
第 11 章部分
- 参考文献
- 调查方法
简介目录
Product Code: CMI2933
Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.
Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.
Market Dynamics
Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.
Key features of the study:
- This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global subcutaneous drug delivery market based on the following parameters-company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
- Global Subcutaneous Drug Delivery Market, Usability
- Disposable
- Reusable
- Global Subcutaneous Drug Delivery Market, Disease Indication
- Auto-immune Disorders
- Neurological Disorders
- Oncology Disorders
- Hormonal Disorders
- Allergy & Infectious Disorders
- Ophthalmic Disorders
- Others
- Global Subcutaneous Drug Delivery Market, Delivery System
- Prefilled Syringes
- Autoinjector
- Spring Type
- Motorized Type
- Wearable Type
- Pen Injectors
- Disposable
- Reusable
- Syringes (Injector)
- Others (pump, etc.)
- Global Subcutaneous Drug Delivery Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Subcutaneous Drug Delivery Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Becton Dickinson and Company,
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novo Nordisk A/S,
- Johnson & Johnson
- Novartis International AG
- Amgen, Inc.
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.,
- Consort Medical plc,
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation,
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- Becton Dickinson and Company,
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Usability
- Market Snapshot, By Disease Indication
- Market Snapshot, By Delivery System
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Merger, Acquisition, and Collaborations
- Product Launch
- Regulatory Scenario
- PEST Analysis
4. Global Subcutaneous Drug Delivery Market- Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Subcutaneous Drug Delivery Market, By Usability, 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Auto-immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Oncology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Hormonal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Allergy & Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Ophthalmic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Auto injector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Pen Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others (pump, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2017-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
9. Global Subcutaneous Drug Delivery Market, By Region, 2017-2030, (US$ Billion)
- Overview
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Billion)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Becton Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk A/S
- Johnson & Johnson.
- Novartis International AG
- Amgen, Inc
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.
- Consort Medical plc.
- LaVision Biotec GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation
- West Pharmaceutical Services, Inc.
- Gerresheimer AG.
11. Section
- References
- Research Methodology
- About us and Sales Contact
